MCRB compared with GENB: revenue, margins and what each company keeps, and the suppliers and customers both name

MCRBSeres Therapeutics, Inc.

Mkt capRevenueRevenue

GENBGenerate Biomedicines, Inc.

Mkt capRevenueRevenue

Compare

MCRBSeres Therapeutics, Inc.

GENBGenerate Biomedicines, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MCRB 11

—Bactheraunlistedsupplier

—CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator)unlistedsupplier

—Crohn's and Colitis Foundationunlistedsupplier

—Columbia Universityunlistedsupplier

7 more · MCRB chain ›

Shared 0

No shared counterparties.

Only GENB 4

AMGNAmgencustomer

NVSNovartis Pharmacustomer

—The University of Texas MD Anderson Cancer Centerunlistedsupplier

—Roswell Park Comprehensive Cancer Center

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

MCRBSeres Therapeutics, Inc.

1.88▲+2.76%

Mkt cap$18.2MRevenue$736,000Q2 FY26

GENBGenerate Biomedicines, Inc.

13.77▲+4.22%

Regular sessionNov 3 '26

Mkt cap$1.7BRevenue$6MQ2 FY26

Compare

Regular sessionNov 3 '26

MCRBSeres Therapeutics, Inc.

GENBGenerate Biomedicines, Inc.

1.88▲+2.76%

Price

13.77▲+4.22%

$18.2M

Mkt cap

$1.7B

Q2 FY26$736,000

Revenue

$6MQ2 FY26

MCRB1.88▲+2.76%vsGENB13.77▲+4.22%Regular sessionNov 3 '26